01020304
ʻO ka Frontier Nui o nā molekole liʻiliʻi--RNA hulina
2024-03-07 15:49:45
Ua manaʻo lōʻihi ʻo ka hoʻohana ʻana i nā kemika e hahai i ka RNA he mea lapuwale ma muli o kāna mau waiwai. Ke holomua ka poʻe ʻepekema, ʻo ka mea maʻamau ma ka pōʻino.
I nā makahiki he ʻumi i hala iho nei, no ka laʻana, ua ʻike ʻo Merck i kahi lāʻau antibiotic hoʻokolohua i ka hoʻomohala ʻana e poloka ana i kahi ʻano RNA bacteria. Ua hina ʻo Pfizer hiki i kāna lāʻau lapaʻau ke hoʻopilikia i ka unuhi ʻana o kahi protein e hoʻoponopono ai i ka cholesterol.
I kēia manawa, manaʻo nā hui lāʻau e hana i kēlā. Me ke kōkua o nā ʻenehana hoʻonohonoho ʻoi aku ka maikaʻi, nā ʻano kānana, a me ka ʻike ākea o ka RNA, hiki i nā mea noiʻi ke hopu maʻalahi i ke ʻano o nā molekele ʻike a hoʻolālā i nā lāʻau lapaʻau e pili ana iā lākou. Inā kūleʻa, hiki iā lākou ke kōkua i ka hoʻokō ʻana i nā pahuhopu maʻi ʻaʻole hiki i nā molekala liʻiliʻi ke hiki i kēia manawa, e hāʻawi ana i nā ala hou e mālama ai i nā maʻi neurodegenerative, ka maʻi kanesa a me nā kūlana ʻē aʻe.
01 He aha nā molekole liʻiliʻi e kuhikuhi ana i ka RNA?
ʻO lākou ka pōhaku kihi o ka ʻoihana lāʻau lapaʻau a lilo i ka hapa nui o nā lāʻau lapaʻau ma ka mākeke. Akā ua kaupalena ʻia ka laulā o nā molekala liʻiliʻi. Ma kahi kokoke i 20,000 mau genes i ʻike ʻia, ma kahi o 3,000 i manaʻo ʻia he mea hoʻopau ʻia, ʻo ia hoʻi hiki ke hoʻopaʻa ʻia me nā lāʻau lapaʻau. ʻO nā protein a lākou e hana ai, he mau haneli wale nō ka mea i manaʻo ʻia no nā lāʻau lapaʻau. ʻAʻole loaʻa nā "ʻeke" ʻē aʻe he nui i nā molekala liʻiliʻi e hoʻokomo ai, e ʻoi aku ka paʻakikī o ka loaʻa ʻana.
ʻO ka huli ʻana i nā molekole RNA e kōkua i ka hana ʻana i nā protein pili i ka maʻi hiki ke hāʻawi i nā mea hana lāʻau i kahi ala ʻē aʻe. Ma ke kumumanaʻo, hiki i ka lāʻau lapaʻau ke pale i ka hana ʻana o kahi protein hiki ke hoʻopōʻino a hana paha i nā protein ʻoi aku ka maikaʻi.
ʻO kekahi ala like, hoʻohana ʻia e Ionis Pharmaceuticals a me nā hui ʻē aʻe, hoʻohana i nā ʻāpana o ka nucleic acid i kapa ʻia ʻo antisense oligonucleotides e hoʻoponopono a hoʻopau i ka hana ʻana o nā protein. Ua holomua nā hui ʻelua i ka noiʻi RNA, ʻoi aku ka huli ʻana i nā lāʻau lapaʻau no ka mālama ʻana i nā maʻi ʻano like ʻole e like me ka spinal muscular atrophy a me ka thyroid transamyloidosis, a me nā kūlana maʻamau e like me ka cholesterol kiʻekiʻe. Hiki i nā hopena o ka lāʻau ke hoʻomau no nā mahina i ka manawa.
ʻOiai ua loaʻa ka holomua nui i ka hāʻawi ʻana i kēia mau lāʻau lapaʻau RNA i loko o ke kino, ua kaupalena ʻia lākou i nā pahuhopu maʻi i loko o ke ake, ʻo ia hoʻi ka nui o nā maʻi hiki ʻole ke mālama ʻia.
03 ʻO nā molekala liʻiliʻi e huli ana i ka RNA ka pae aʻe.
ʻO ka mea mua i hana pēlā ʻo Evrysdi, kahi lāʻau i hoʻomohala ʻia e Roche a me PTC Therapeutics a ʻae ʻia i 2020 e kōkua i ka hana ʻana i kahi protein i nele i nā mea maʻi me ka spinal muscular atrophy. ʻO kahi lāʻau maʻi maʻi Huntington hoʻokolohua mai Novartis i kapa ʻia ʻo branaplam aia pū kekahi i nā hoʻokolohua kanaka, akā hiki i nā pilikia palekana hou ke keʻakeʻa i kona holomua.
I kēia manawa, ʻaʻohe mea hoʻomaka e hoʻomohala ana i nā molekole RNA-targeting liʻiliʻi i lawe i kahi lāʻau lapaʻau i nā hoʻokolohua lapaʻau. Akā ke hoʻomaka nei nā paipu o kekahi ʻoihana. ʻIke ʻia ʻo Skyhawk i ka pō o ke komo ʻana i nā hoʻokolohua lapaʻau, a ua ʻōlelo mua ka ʻoihana e hoʻolālā ana e hoʻomaka i ka neʻe ʻana i kāna lāʻau lapaʻau mua i nā hoʻokolohua kanaka i kekahi manawa o kēia makahiki.










